These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 28489483)

  • 21. Breaking the vicious circle: Onabotulinum toxin A in children with therapy-refractory dysfunctional voiding.
    't Hoen LA; van den Hoek J; Wolffenbuttel KP; van der Toorn F; Scheepe JR
    J Pediatr Urol; 2015 Jun; 11(3):119.e1-6. PubMed ID: 25794865
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of axillary bromhidrosis in adolescents by combining electrocauterization with ultrasound-guided botulinum toxin type A injection.
    Chen W; Zhang X; Zhang L; Xu Y
    J Plast Reconstr Aesthet Surg; 2021 Nov; 74(11):3114-3119. PubMed ID: 34238698
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endoscopic injection of botulinum toxin for biliary sphincter of Oddi dysfunction.
    Wehrmann T; Seifert H; Seipp M; Lembcke B; Caspary WF
    Endoscopy; 1998 Oct; 30(8):702-7. PubMed ID: 9865560
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A treatment protocol for botulinum toxin injections in the treatment of pachyonychia congenita-associated keratoderma.
    Koren A; Sprecher E; Reider E; Artzi O
    Br J Dermatol; 2020 Mar; 182(3):671-677. PubMed ID: 31127950
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety and prolonged efficacy of Botulin Toxin A in primary hyperhidrosis.
    D'Epiro S; Macaluso L; Salvi M; Luci C; Mattozzi C; Marzocca F; Salvo V; Scarnò M; Calvieri S; Richetta AG
    Clin Ter; 2014; 165(6):e395-400. PubMed ID: 25524193
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Repetitive injections of botulinum toxin A continuously increase the duration of efficacy in primary axillary hyperhidrosis: a retrospective analysis in 101 patients.
    Brehmer F; Lockmann A; Grönemeyer LL; Kretschmer L; Schön MP; Thoms KM
    J Dtsch Dermatol Ges; 2015 Aug; 13(8):799-805. PubMed ID: 26176740
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Duration of botulinum toxin effect in the treatment of crocodile tears.
    Nava-Castañeda A; Tovilla-Canales JL; Boullosa V; Tovilla-y-Pomar JL; Monroy-Serrano MH; Tapia-Guerra V; Garfias Y
    Ophthalmic Plast Reconstr Surg; 2006; 22(6):453-6. PubMed ID: 17117101
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Botulinum Toxin Treatment for Nocturnal Calf Cramps in Patients With Lumbar Spinal Stenosis: A Randomized Clinical Trial.
    Park SJ; Yoon KB; Yoon DM; Kim SH
    Arch Phys Med Rehabil; 2017 May; 98(5):957-963. PubMed ID: 28209505
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Same-patient prospective comparison of Botox versus Dysport for the treatment of primary axillary hyperhidrosis and review of literature.
    Vergilis-Kalner IJ
    J Drugs Dermatol; 2011 Sep; 10(9):1013-5. PubMed ID: 22052270
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Using Neuromodulators for Salivary, Eccrine, and Apocrine Gland Disorders.
    Rajanala S; Salame N; Dover JS
    Dermatol Surg; 2024 Sep; 50(9S):S103-S111. PubMed ID: 39196843
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Botulinum toxin a treatment in children with cerebral palsy: its effects on walking and energy expenditure.
    Balaban B; Tok F; Tan AK; Matthews DJ
    Am J Phys Med Rehabil; 2012 Jan; 91(1):53-64. PubMed ID: 22157436
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Variability of the immunologic and clinical response in dystonic patients immunoresistant to botulinum toxin injections.
    Sankhla C; Jankovic J; Duane D
    Mov Disord; 1998 Jan; 13(1):150-4. PubMed ID: 9452341
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Botulinum toxin type A for the treatment of trigeminal neuralgia: results from a randomized, double-blind, placebo-controlled trial.
    Wu CJ; Lian YJ; Zheng YK; Zhang HF; Chen Y; Xie NC; Wang LJ
    Cephalalgia; 2012 Apr; 32(6):443-50. PubMed ID: 22492424
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Botulinum toxin for glabellar lines: a review of the efficacy and safety of currently available products.
    Dessy LA; Fallico N; Mazzocchi M; Scuderi N
    Am J Clin Dermatol; 2011 Dec; 12(6):377-88. PubMed ID: 21877763
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A pilot study of botulinum toxin A for male chronic pelvic pain syndrome.
    Gottsch HP; Yang CC; Berger RE
    Scand J Urol Nephrol; 2011 Feb; 45(1):72-6. PubMed ID: 21062115
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined modality treatment of adductor spasmodic dysphonia.
    Silverman EP; Garvan C; Shrivastav R; Sapienza CM
    J Voice; 2012 Jan; 26(1):77-86. PubMed ID: 21292439
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Botulinum toxin A and B: a comparative dosing study for spasmodic dysphonia.
    Blitzer A
    Otolaryngol Head Neck Surg; 2005 Dec; 133(6):836-8. PubMed ID: 16360499
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improvement in pelvic pain with botulinum toxin type A - Single vs. repeat injections.
    Nesbitt-Hawes EM; Won H; Jarvis SK; Lyons SD; Vancaillie TG; Abbott JA
    Toxicon; 2013 Mar; 63():83-7. PubMed ID: 23220489
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
    Wissel J; Entner T
    Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Constraint-Induced Movement Therapy After Injection of Botulinum Toxin Type A for a Patient With Chronic Stroke: One-Year Follow-up Case Report.
    Amano S; Takebayashi T; Hanada K; Umeji A; Marumoto K; Furukawa K; Domen K
    Phys Ther; 2015 Jul; 95(7):1039-45. PubMed ID: 25592185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.